Concert Pharmaceuticals - Building Better Medicinse
About Us Research & Development News Careers Contact Us
About Us
 

Company Overview

Management

Board of Directors

Product Advisory Board

Investors

Business Development

 
 

Company Overview

Founded in April 2006, Concert Pharmaceuticals is the first company dedicated to creating new medicines through a novel scientific approach utilizing the naturally-occurring element deuterium.

Concert applies its innovative precision deuterium chemistry platform to modify specific properties of validated drug molecules, yielding a rich pipeline of new chemical entities (NCEs). Concert leverages decades of pharmaceutical experience to create novel drug candidates with potential for best-in-class efficacy and safety, while greatly reducing R&D risk, time and expense.

The Company has over 100 patent applications for new drug candidates addressing a broad range of therapeutic areas, including hot flashes, fibrotic diseases, pain and infectious disease. Concert expects to initiate its first clinical study in 2008.

Concert is a rapidly growing company with an entrepreneurial culture based in Lexington, Massachusetts. The Company is led by an experienced management team and Board of Directors, and is supported by top-tier venture capitalists and leading crossover funds. Concert has raised $95.5 million since its inception.

[ back to top ]

 
  ©2008 Concert Pharmaceuticals, Inc.
Design by Digizyme
 
Home     Sitemap